Mantle Cell Lymphoma Treatment Market Report

Global and Region Mantle Cell Lymphoma Treatment Market Demand & Opportunity Outlook 2022-2028

  • POSTDATE：Aug 03, 2022
  • PAGES：176
  • REPORT CODE：GMM1009785
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • The report details the trend, potential and market size of Mantle Cell Lymphoma Treatment market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.

    The first part (Chapter1-7) mainly covers the qualitative analysis of Mantle Cell Lymphoma Treatmentmarket, defines the market attractiveness level of Mantle Cell Lymphoma Treatment market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.

    The second part (Chapter8-12), based on the segmentation of Mantle Cell Lymphoma Treatment industry, describes the types of Mantle Cell Lymphoma Treatment market, the applications of major players and the market size, and deeply analyzes the current situation of the global Mantle Cell Lymphoma Treatment market and the development prospects and opportunities of Mantle Cell Lymphoma Treatment industry.

    The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.

    As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Mantle Cell Lymphoma Treatment market in Chapter 13.

    By Player:

    • Immunomedics, Inc

    • GlaxoSmithKline Plc

    • Bayer AG

    • Hutchison MediPharma Limited

    • EpiZyme, Inc

    • Gilead Sciences, Inc

    • Celgene Corporation

    • Cellular Biomedicine Group, Inc

    • Genentech, Inc

    • Bristol-Myers Squibb Company

    • Fate Therapeutics, Inc

    • ImmunoGen, Inc

    • Astex Pharmaceuticals, Inc

    • Eisai

    By Type:

    • Acalabrutinib

    • JCAR-017

    • JNJ-64052781

    • Acalisib

    • IGN-002

    • IMGN-529

    • AFM-11

    • Others

    By End-User:

    • Hospital

    • Clinic

    • Others

    By Geography:

    • United States

    • Europe

    • China

    • Japan

    • India

    • South Korea

  • TABLE OF CONTENT

    1 Introduction

    • 1.1 Market Definition

    • 1.2 Market Segment Analysis

    • 1.3 Market Size 2022

    • 1.4 Mantle Cell Lymphoma Treatment Market Outlook: Forecast for 2022 - 2028

    • 1.5 Pricing Analysis

    2 Executive Summary

    3 Mantle Cell Lymphoma Treatment Market Lineage Outlook

    • 3.1 Parent Market Outlook

    • 3.2 Related/Ancillary Market Outlook

    • 3.3 Penetration & Growth Prospect Mapping, 2022

    4 Market Analysis Tools: Porter's Five Forces

    • 4.1 Supplier Power

    • 4.2 Buyer Power

    • 4.3 Substitution Threat

    • 4.4 Threat of New Entrants

    • 4.5 Competitive Rivalry

    5 Mantle Cell Lymphoma Treatment Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)

    • 5.1 Political/Legal Landscape

    • 5.2 Economic Landscape

    • 5.3 Social Landscape

    • 5.4 Technology Landscape

    6 Mantle Cell Lymphoma Treatment Market - Value Chain Analysis

    • 6.1 Industry's Value Chain Analysis

    • 6.2 Product Life Cycle

    • 6.3 User Perspective Analysis

    7 Region and Country-wise Mantle Cell Lymphoma Treatment Market Analysis and Outlook to 2022

    • 7.1 Global Mantle Cell Lymphoma Treatment Consumption (2017-2022)

    • 7.2 United States Mantle Cell Lymphoma Treatment Consumption (2017-2022)

    • 7.3 Europe Mantle Cell Lymphoma Treatment Consumption (2017-2022)

    • 7.4 China Mantle Cell Lymphoma Treatment Consumption (2017-2022)

    • 7.5 Japan Mantle Cell Lymphoma Treatment Consumption (2017-2022)

    • 7.6 India Mantle Cell Lymphoma Treatment Consumption (2017-2022)

    • 7.7 South Korea Mantle Cell Lymphoma Treatment Consumption (2017-2022)

    8 Region and Country-wise Mantle Cell Lymphoma Treatment Market Analysis and Outlook to 2028

    • 8.1 Global Mantle Cell Lymphoma Treatment Consumption Forecast (2022-2028)

    • 8.2 United States Mantle Cell Lymphoma Treatment Consumption Forecast (2022-2028)

    • 8.3 Europe Mantle Cell Lymphoma Treatment Consumption Forecast (2022-2028)

    • 8.4 China Mantle Cell Lymphoma Treatment Consumption Forecast (2022-2028)

    • 8.5 Japan Mantle Cell Lymphoma Treatment Consumption Forecast (2022-2028)

    • 8.6 India Mantle Cell Lymphoma Treatment Consumption Forecast (2022-2028)

    • 8.7 South Korea Mantle Cell Lymphoma Treatment Consumption Forecast (2022-2028)

    9 Global Mantle Cell Lymphoma Treatment Market Outlook by Types and Applications to 2022

    • 9.1 Global Mantle Cell Lymphoma Treatment Consumption and Growth Rate by Type (2017-2022)

      • 9.1.1 Global Acalabrutinib Consumption and Growth Rate (2017-2022)

      • 9.1.2 Global JCAR-017 Consumption and Growth Rate (2017-2022)

      • 9.1.3 Global JNJ-64052781 Consumption and Growth Rate (2017-2022)

      • 9.1.4 Global Acalisib Consumption and Growth Rate (2017-2022)

      • 9.1.5 Global IGN-002 Consumption and Growth Rate (2017-2022)

      • 9.1.6 Global IMGN-529 Consumption and Growth Rate (2017-2022)

      • 9.1.7 Global AFM-11 Consumption and Growth Rate (2017-2022)

      • 9.1.8 Global Others Consumption and Growth Rate (2017-2022)

    • 9.2 Global Mantle Cell Lymphoma Treatment Consumption and Growth Rate by Application (2017-2022)

      • 9.2.1 Global Hospital Consumption and Growth Rate (2017-2022)

      • 9.2.2 Global Clinic Consumption and Growth Rate (2017-2022)

      • 9.2.3 Global Others Consumption and Growth Rate (2017-2022)

    10 Global Mantle Cell Lymphoma Treatment Market Outlook by Types and Applications to 2028

    • 10.1 Global Mantle Cell Lymphoma Treatment Consumption Forecast and Growth Rate by Type (2022-2028)

      • 10.1.1 Global Acalabrutinib Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.2 Global JCAR-017 Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.3 Global JNJ-64052781 Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.4 Global Acalisib Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.5 Global IGN-002 Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.6 Global IMGN-529 Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.7 Global AFM-11 Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.8 Global Others Consumption Forecast and Growth Rate (2022-2028)

    • 10.2 Global Mantle Cell Lymphoma Treatment Consumption Forecast and Growth Rate by Application (2022-2028)

      • 10.2.1 Global Hospital Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.2 Global Clinic Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.3 Global Others Consumption Forecast and Growth Rate (2022-2028)

    11 Global Mantle Cell Lymphoma Treatment Import and Export Analysis (Top 5 Countries)

    • 11.1 Global Mantle Cell Lymphoma Treatment Import by Region (Top 5 Countries) (2017-2028)

    • 11.2 Global Mantle Cell Lymphoma Treatment Export by Region (Top 5 Countries) (2017-2028)

    12 Coronavirus Disease (COVID-19) Impact

    • 12.1 Industry Impact Analysis

    • 12.2 Mantle Cell Lymphoma Treatment Market Outlook to 2028 - COVID-19 Affected Forecasts

    13 Competition Matrix

    • 13.1 Target Markets

    • 13.2 Comprehensive Analysis of Products in Competitive Markets

    14 Global Mantle Cell Lymphoma Treatment Market Competitive Analysis

    • 14.1 Immunomedics, Inc

      • 14.1.1 Immunomedics, Inc Company Details

      • 14.1.2 Immunomedics, Inc Mantle Cell Lymphoma Treatment Sales, Price, Value and Gross Profit (2017-2022)

      • 14.1.3 Immunomedics, Inc Mantle Cell Lymphoma Treatment Product and Service

    • 14.2 GlaxoSmithKline Plc

      • 14.2.1 GlaxoSmithKline Plc Company Details

      • 14.2.2 GlaxoSmithKline Plc Mantle Cell Lymphoma Treatment Sales, Price, Value and Gross Profit (2017-2022)

      • 14.2.3 GlaxoSmithKline Plc Mantle Cell Lymphoma Treatment Product and Service

    • 14.3 Bayer AG

      • 14.3.1 Bayer AG Company Details

      • 14.3.2 Bayer AG Mantle Cell Lymphoma Treatment Sales, Price, Value and Gross Profit (2017-2022)

      • 14.3.3 Bayer AG Mantle Cell Lymphoma Treatment Product and Service

    • 14.4 Hutchison MediPharma Limited

      • 14.4.1 Hutchison MediPharma Limited Company Details

      • 14.4.2 Hutchison MediPharma Limited Mantle Cell Lymphoma Treatment Sales, Price, Value and Gross Profit (2017-2022)

      • 14.4.3 Hutchison MediPharma Limited Mantle Cell Lymphoma Treatment Product and Service

    • 14.5 EpiZyme, Inc

      • 14.5.1 EpiZyme, Inc Company Details

      • 14.5.2 EpiZyme, Inc Mantle Cell Lymphoma Treatment Sales, Price, Value and Gross Profit (2017-2022)

      • 14.5.3 EpiZyme, Inc Mantle Cell Lymphoma Treatment Product and Service

    • 14.6 Gilead Sciences, Inc

      • 14.6.1 Gilead Sciences, Inc Company Details

      • 14.6.2 Gilead Sciences, Inc Mantle Cell Lymphoma Treatment Sales, Price, Value and Gross Profit (2017-2022)

      • 14.6.3 Gilead Sciences, Inc Mantle Cell Lymphoma Treatment Product and Service

    • 14.7 Celgene Corporation

      • 14.7.1 Celgene Corporation Company Details

      • 14.7.2 Celgene Corporation Mantle Cell Lymphoma Treatment Sales, Price, Value and Gross Profit (2017-2022)

      • 14.7.3 Celgene Corporation Mantle Cell Lymphoma Treatment Product and Service

    • 14.8 Cellular Biomedicine Group, Inc

      • 14.8.1 Cellular Biomedicine Group, Inc Company Details

      • 14.8.2 Cellular Biomedicine Group, Inc Mantle Cell Lymphoma Treatment Sales, Price, Value and Gross Profit (2017-2022)

      • 14.8.3 Cellular Biomedicine Group, Inc Mantle Cell Lymphoma Treatment Product and Service

    • 14.9 Genentech, Inc

      • 14.9.1 Genentech, Inc Company Details

      • 14.9.2 Genentech, Inc Mantle Cell Lymphoma Treatment Sales, Price, Value and Gross Profit (2017-2022)

      • 14.9.3 Genentech, Inc Mantle Cell Lymphoma Treatment Product and Service

    • 14.10 Bristol-Myers Squibb Company

      • 14.10.1 Bristol-Myers Squibb Company Company Details

      • 14.10.2 Bristol-Myers Squibb Company Mantle Cell Lymphoma Treatment Sales, Price, Value and Gross Profit (2017-2022)

      • 14.10.3 Bristol-Myers Squibb Company Mantle Cell Lymphoma Treatment Product and Service

    • 14.11 Fate Therapeutics, Inc

      • 14.11.1 Fate Therapeutics, Inc Company Details

      • 14.11.2 Fate Therapeutics, Inc Mantle Cell Lymphoma Treatment Sales, Price, Value and Gross Profit (2017-2022)

      • 14.11.3 Fate Therapeutics, Inc Mantle Cell Lymphoma Treatment Product and Service

    • 14.12 ImmunoGen, Inc

      • 14.12.1 ImmunoGen, Inc Company Details

      • 14.12.2 ImmunoGen, Inc Mantle Cell Lymphoma Treatment Sales, Price, Value and Gross Profit (2017-2022)

      • 14.12.3 ImmunoGen, Inc Mantle Cell Lymphoma Treatment Product and Service

    • 14.13 Astex Pharmaceuticals, Inc

      • 14.13.1 Astex Pharmaceuticals, Inc Company Details

      • 14.13.2 Astex Pharmaceuticals, Inc Mantle Cell Lymphoma Treatment Sales, Price, Value and Gross Profit (2017-2022)

      • 14.13.3 Astex Pharmaceuticals, Inc Mantle Cell Lymphoma Treatment Product and Service

    • 14.14 Eisai

      • 14.14.1 Eisai Company Details

      • 14.14.2 Eisai Mantle Cell Lymphoma Treatment Sales, Price, Value and Gross Profit (2017-2022)

      • 14.14.3 Eisai Mantle Cell Lymphoma Treatment Product and Service

    15 Appendix


    TABLE OF CHARTS

    • Table Definition of Mantle Cell Lymphoma Treatment

    • Figure Mantle Cell Lymphoma Treatment Picture

    • Table Global Mantle Cell Lymphoma Treatment Market Size and Forecast 2022 - 2028 (USD million)

    • Figure Global Mantle Cell Lymphoma Treatment Market Size and Forecast 2022 - 2028 (USD million)

    • Figure Global Mantle Cell Lymphoma Treatment Market: Year-over-year Growth 2022 - 2028 (%)

    • Table Parent Market Analysis

    • Figure Parent Market Price

    • Table Related/Ancillary Market Outlook Analysis

    • Table Supplier Power Analysis

    • Table Buyer Power Analysis

    • Table Substitution Threat Analysis

    • Table Threat of New Entrants Analysis

    • Table Competitive Rivalry Analysis

    • Figure Global Mantle Cell Lymphoma Treatment Consumption by Country (2017-2022)

    • Figure United States Mantle Cell Lymphoma Treatment Consumption and Growth Rate (2017-2022)

    • Table Europe Mantle Cell Lymphoma Treatment Consumption and Growth Rate (2017-2022)

    • Figure China Mantle Cell Lymphoma Treatment Consumption and Growth Rate (2017-2022)

    • Figure Japan Mantle Cell Lymphoma Treatment Consumption and Growth Rate (2017-2022)

    • Figure India Mantle Cell Lymphoma Treatment Consumption and Growth Rate (2017-2022)

    • Figure South Korea Mantle Cell Lymphoma Treatment Consumption and Growth Rate (2017-2022)

    • Figure Global Mantle Cell Lymphoma Treatment Consumption Forecast by Country (2022-2028)

    • Figure United States Mantle Cell Lymphoma Treatment Consumption Forecast and Growth Rate (2022-2028)

    • Table Europe Mantle Cell Lymphoma Treatment Consumption Forecast and Growth Rate (2022-2028)

    • Figure China Mantle Cell Lymphoma Treatment Consumption Forecast and Growth Rate (2022-2028)

    • Figure Japan Mantle Cell Lymphoma Treatment Consumption Forecast and Growth Rate (2022-2028)

    • Figure India Mantle Cell Lymphoma Treatment Consumption Forecast and Growth Rate (2022-2028)

    • Figure South Korea Mantle Cell Lymphoma Treatment Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Acalabrutinib Consumption and Growth Rate (2017-2022)

    • Figure Global JCAR-017 Consumption and Growth Rate (2017-2022)

    • Figure Global JNJ-64052781 Consumption and Growth Rate (2017-2022)

    • Figure Global Acalisib Consumption and Growth Rate (2017-2022)

    • Figure Global IGN-002 Consumption and Growth Rate (2017-2022)

    • Figure Global IMGN-529 Consumption and Growth Rate (2017-2022)

    • Figure Global AFM-11 Consumption and Growth Rate (2017-2022)

    • Figure Global Others Consumption and Growth Rate (2017-2022)

    • Figure Global Hospital Consumption and Growth Rate (2017-2022)

    • Figure Global Clinic Consumption and Growth Rate (2017-2022)

    • Figure Global Others Consumption and Growth Rate (2017-2022)

    • Figure Global Acalabrutinib Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global JCAR-017 Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global JNJ-64052781 Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Acalisib Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global IGN-002 Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global IMGN-529 Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global AFM-11 Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Others Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Hospital Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Clinic Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Others Consumption Forecast and Growth Rate (2022-2028)

    • Table Global Mantle Cell Lymphoma Treatment Import by Region (Top 5 Countries) (2017-2028)

    • Table Global Mantle Cell Lymphoma Treatment Export by Region (Top 5 Countries) (2017-2028)

    • Table Immunomedics, Inc (Foundation Year, Company Profile and etc.)

    • Table Immunomedics, Inc Mantle Cell Lymphoma Treatment Sales, Price, Value and Gross Profit (2017-2022)

    • Table Immunomedics, Inc Mantle Cell Lymphoma Treatment Product and Service

    • Table GlaxoSmithKline Plc (Foundation Year, Company Profile and etc.)

    • Table GlaxoSmithKline Plc Mantle Cell Lymphoma Treatment Sales, Price, Value and Gross Profit (2017-2022)

    • Table GlaxoSmithKline Plc Mantle Cell Lymphoma Treatment Product and Service

    • Table Bayer AG (Foundation Year, Company Profile and etc.)

    • Table Bayer AG Mantle Cell Lymphoma Treatment Sales, Price, Value and Gross Profit (2017-2022)

    • Table Bayer AG Mantle Cell Lymphoma Treatment Product and Service

    • Table Hutchison MediPharma Limited (Foundation Year, Company Profile and etc.)

    • Table Hutchison MediPharma Limited Mantle Cell Lymphoma Treatment Sales, Price, Value and Gross Profit (2017-2022)

    • Table Hutchison MediPharma Limited Mantle Cell Lymphoma Treatment Product and Service

    • Table EpiZyme, Inc (Foundation Year, Company Profile and etc.)

    • Table EpiZyme, Inc Mantle Cell Lymphoma Treatment Sales, Price, Value and Gross Profit (2017-2022)

    • Table EpiZyme, Inc Mantle Cell Lymphoma Treatment Product and Service

    • Table Gilead Sciences, Inc (Foundation Year, Company Profile and etc.)

    • Table Gilead Sciences, Inc Mantle Cell Lymphoma Treatment Sales, Price, Value and Gross Profit (2017-2022)

    • Table Gilead Sciences, Inc Mantle Cell Lymphoma Treatment Product and Service

    • Table Celgene Corporation (Foundation Year, Company Profile and etc.)

    • Table Celgene Corporation Mantle Cell Lymphoma Treatment Sales, Price, Value and Gross Profit (2017-2022)

    • Table Celgene Corporation Mantle Cell Lymphoma Treatment Product and Service

    • Table Cellular Biomedicine Group, Inc (Foundation Year, Company Profile and etc.)

    • Table Cellular Biomedicine Group, Inc Mantle Cell Lymphoma Treatment Sales, Price, Value and Gross Profit (2017-2022)

    • Table Cellular Biomedicine Group, Inc Mantle Cell Lymphoma Treatment Product and Service

    • Table Genentech, Inc (Foundation Year, Company Profile and etc.)

    • Table Genentech, Inc Mantle Cell Lymphoma Treatment Sales, Price, Value and Gross Profit (2017-2022)

    • Table Genentech, Inc Mantle Cell Lymphoma Treatment Product and Service

    • Table Bristol-Myers Squibb Company (Foundation Year, Company Profile and etc.)

    • Table Bristol-Myers Squibb Company Mantle Cell Lymphoma Treatment Sales, Price, Value and Gross Profit (2017-2022)

    • Table Bristol-Myers Squibb Company Mantle Cell Lymphoma Treatment Product and Service

    • Table Fate Therapeutics, Inc (Foundation Year, Company Profile and etc.)

    • Table Fate Therapeutics, Inc Mantle Cell Lymphoma Treatment Sales, Price, Value and Gross Profit (2017-2022)

    • Table Fate Therapeutics, Inc Mantle Cell Lymphoma Treatment Product and Service

    • Table ImmunoGen, Inc (Foundation Year, Company Profile and etc.)

    • Table ImmunoGen, Inc Mantle Cell Lymphoma Treatment Sales, Price, Value and Gross Profit (2017-2022)

    • Table ImmunoGen, Inc Mantle Cell Lymphoma Treatment Product and Service

    • Table Astex Pharmaceuticals, Inc (Foundation Year, Company Profile and etc.)

    • Table Astex Pharmaceuticals, Inc Mantle Cell Lymphoma Treatment Sales, Price, Value and Gross Profit (2017-2022)

    • Table Astex Pharmaceuticals, Inc Mantle Cell Lymphoma Treatment Product and Service

    • Table Eisai (Foundation Year, Company Profile and etc.)

    • Table Eisai Mantle Cell Lymphoma Treatment Sales, Price, Value and Gross Profit (2017-2022)

    • Table Eisai Mantle Cell Lymphoma Treatment Product and Service


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US